Ledger.Open graph →
SEC Form D · Amendment · filed November 10, 2014

Erytech Pharma

Offering
—
Sold
$37.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LYON, I0
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Pierre-Olivier Goineau · LYON, I0Exec · Director · PromoterGil Beyen · LYON, I0Exec · DirectorYann Godfrin · LYON, I0Exec · Director · PromoterNeil A. Cox · LONGMONT, COExec · Director · PromoterJoseph J. Scaravilli · Beachwood, OHExec · Director · PromoterGalenos · IXELLES, C9DirectorMartine George · SKILLMAN, NJDirectorPhilippe Archinard · TASSIN-LA-DEMI-LUNE, I0DirectorHilde Windels · MOORTSELE, C9DirectorJerome Bailly · CHASSIEU, I0ExecMichael A. Willis · BOULDER, COExec · Director · PromoterWilliam A. Kent · BOULDER, COExec · Director · PromoterZung V. Tran · ERIE, COExec · DirectorGalenos · IXELLES, C9DirectorMartine George · SKILLMAN, NJDirectorPhilippe Archinard · TASSIN-LA-DEMI-LUNE, I0DirectorHilde Windels · MOORTSELE, C9DirectorJerome Bailly · CHASSIEU, I0Exec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗